Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Somatic to iPS Cell Reprogramming01:29

Somatic to iPS Cell Reprogramming

2.6K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.6K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

5.5K
The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
5.5K
Abnormal Proliferation02:23

Abnormal Proliferation

5.1K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The entropic view of aging: from thermodynamics to biology.

Life medicine·2026
Same author

ZNF512B safeguards genome integrity at regulatory regions to repress the SASP and inflammation.

Cell stem cell·2026
Same author

Single-nucleus interrogation of primate small intestinal aging reveals NCoR1 decline as a conserved feature that is reversed by metformin.

Nature aging·2026
Same author

Author Correction: CHIT1-positive microglia drive motor neuron ageing in the primate spinal cord.

Nature·2026
Same author

Mesenchymal drift: A convergent framework for the hallmarks of aging.

Cell·2026
Same author

Multimorbidity defines glycaemic individuality in ageing.

Nature metabolism·2026

Related Experiment Video

Updated: Jan 10, 2026

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation
09:23

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation

Published on: February 13, 2017

8.9K

Reprogramming the GRHL2-CDK19 axis by gene therapy alleviates prostate aging.

Guoqiang Sun1, Zan He2, Dongliang Lv1,3

  • 1State Key Laboratory of Organ Regeneration and Reconstruction, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.

Nature Aging
|November 20, 2025
PubMed
Summary
This summary is machine-generated.

Prostate aging involves cell senescence, inflammation, and fibrosis. A GRHL2 gene therapy approach successfully delayed aging and improved urinary function in primates.

More Related Videos

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

9.1K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

47.4K

Related Experiment Videos

Last Updated: Jan 10, 2026

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation
09:23

A Rapid Filter Insert-based 3D Culture System for Primary Prostate Cell Differentiation

Published on: February 13, 2017

8.9K
Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration
06:21

Virus Delivery of CRISPR Guides to the Murine Prostate for Gene Alteration

Published on: April 27, 2018

9.1K
Murine Prostate Micro-dissection and Surgical Castration
08:49

Murine Prostate Micro-dissection and Surgical Castration

Published on: May 11, 2016

47.4K

Area of Science:

  • Urology
  • Aging Research
  • Molecular Biology

Background:

  • The aging prostate significantly impacts male quality of life, affecting sexual and urinary functions, fertility, and disease susceptibility.
  • Mechanisms driving human prostate aging are not well understood, necessitating further research.

Purpose of the Study:

  • To elucidate the molecular mechanisms underlying primate prostate aging.
  • To identify key cellular and molecular changes associated with prostate aging.

Main Methods:

  • Integration of single-nucleus transcriptomics and histological analyses in primate prostates.
  • Investigation of the role of GRHL2, CDK19, p53, and p21Waf1/Cip1 in prostate aging.

Main Results:

  • Identified epithelial cell senescence, chronic inflammation, and fibrosis as hallmarks of prostate aging.
  • Demonstrated that GRHL2 downregulation in aging leads to p53 activation and p21Waf1/Cip1-induced senescence.
  • Showcased that GRHL2-based gene therapy effectively delays prostate aging and alleviates urinary dysfunction in vivo.

Conclusions:

  • Elucidated key molecular mechanisms driving primate prostate aging, focusing on the GRHL2-CDK19-p53-p21Waf1/Cip1 pathway.
  • Established epithelial cell senescence as a critical factor in prostate aging.
  • Provided a foundation for developing novel therapeutic strategies targeting prostate aging and related conditions.